• ICE
  • NYSE
  • Contact
  • Insights
Episode 162

David Fischel, CEO of Stereotaxis, is leading a robot revolution in the O.R.

36 minutes · February 24, 2020

Get the robot in here, STAT! Surgery is going digital by leveraging artificial intelligence, telemedicine, and big data to bring cutting edge care to patients across the globe. David Fischel is CEO of Stereotaxis (NYSEAMERICAN:STXS), one of the companies leading this sea change. He dropped by the NYSE to talk about the company’s advancements, including bringing Genesis, a new robotic magnetic navigation technology, to market. David also forecasts the future of machine-augmented medicine and how Stereotaxis provide the tools that surgeons will need in the operating rooms of the future.

David Fischel

Podcast Archive

Subscribe to episodes

  • Listen on Apple Podcasts
  • Listen on Stitcher
  • Listen on Google Play Music
  • Spotify
  • Listen on Himalaya
  • RSS

Information contained in this podcast was obtained in part from publicly available sources, and not independently verified. Neither ICE nor its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the information and do not sponsor, approve, or endorse any of the content herein, all of which is presented solely for informational and educational purposes. Nothing herein constitutes an offer to sell, a solicitation of an offer to buy any security, or a recommendation of any security or trading practice.